Related Experiment Videos
Is porphyria cutanea tarda a paraneoplastic disorder?
1Department of Dermatology, New York Medical College, Valhalla 10595.
Clinics in Dermatology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Theodore Woodward Award. Pathogenesis of biochemical abnormalities in protoporphyria.
Transactions of the American Clinical and Climatological Association·2000
Mutations in the translation initiation codon of the protoporphyrinogen oxidase gene underlie variegate porphyria.
Clinical and experimental dermatology·1999
Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research·1999
Haplotype analysis of families with erythropoietic protoporphyria and novel mutations of the ferrochelatase gene.
The Journal of investigative dermatology·1999
C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
Annals of human genetics·1998
The genetic basis of "Scarsdale Gourmet Diet" variegate porphyria: a missense mutation in the protoporphyrinogen oxidase gene.
Archives of dermatological research·1998
Ethical Responsibilities of Phyisician Inventors: Access and Justice.
Clinics in dermatology·2026
Ethical Issues Surrounding Maternity/Paternity Leave.
Clinics in dermatology·2026
Genital Herpes Counseling: Ethical Considerations in Confidentiality, Disclosure, and Psychosocial Harm.
Clinics in dermatology·2026
"Mechanism of action: GLP-1 receptors in skin biology".
Clinics in dermatology·2026
Inclusive designs that allow the inclusion of a broader population in randomized controlled trials: An evaluation of randomization ratio and analysis strategy.
Statistical methods in medical research·2026
A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Clinically Relevant Outcomes With Romiplostim in Patients With Solid Tumors and Persistent Chemotherapy Induced Thrombocytopenia.
American journal of hematology·2026